HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Conditions:   Human Papillomavirus Type 16;   Cervical Intraepithelial Neoplasia Grade II;   Cervical Intraepithelial Neoplasia, Grade III Intervention:   Drug: pNGVL4aCRTE6E7L2 Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials